サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1218756

パーソナライズド・メディシンの世界市場

Personalized Medicines
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 216 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
パーソナライズド・メディシンの世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 216 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

パーソナライズド・メディシンの世界市場は2030年に7,403億米ドルに達する

変化したCOVID-19後のビジネス環境において、2022年に5080億米ドルと推定されるパーソナライズド・メディシンの世界市場は、2030年までに7403億米ドルの改定規模に達し、分析期間2022-2030年に4.8%のCAGRで成長すると予測されます。本レポートで分析したセグメントの1つであるパーソナライズド・ニュートリション＆ウェルネスは、CAGR4.6%を記録し、分析期間終了時には4,379億米ドルに達すると予測されます。パンデミック後の回復を考慮し、個別化医療分野の成長は、今後8年間のCAGRが5.2%に修正されました。

米国市場は1,486億米ドル、中国はCAGR4.5%で成長すると予測されます。

米国のパーソナライズド・メディシン市場は、2022年には1,486億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが4.5％となり、2030年には1,303億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ4.3%と4%の成長が予測されています。欧州では、ドイツがCAGR3.7%で成長すると予測されています。

調査対象企業の例

  • Abbott Molecular
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Dako Denmark A/S
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hologic, Inc.
  • Lab 21 Limited
  • Macrogen, Inc.
  • NeoGenomics Laboratories, Inc.
  • Novartis AG
  • QIAGEN NV
  • Rosetta Genomics Ltd.
  • Thermo Fischer Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-7877

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Personalized Medicines Market to Reach $740.3 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Personalized Medicines estimated at US$508 Billion in the year 2022, is projected to reach a revised size of US$740.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030. Personalized Nutrition & Wellness, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$437.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Personalized Medical Care segment is readjusted to a revised 5.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $148.6 Billion, While China is Forecast to Grow at 4.5% CAGR

The Personalized Medicines market in the U.S. is estimated at US$148.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$130.3 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Select Competitors (Total 87 Featured):

  • Abbott Molecular
  • Beckman Coulter, Inc.
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Dako Denmark A/S
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hologic, Inc.
  • Lab 21 Limited
  • Macrogen, Inc.
  • NeoGenomics Laboratories, Inc.
  • Novartis AG
  • QIAGEN NV
  • Rosetta Genomics Ltd.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Access to Valuable Genetic Information Ushers Transformation in Medicine
    • Recent Market Activity
    • Market Outlook
    • Adoption of Personalized Medicines - A Peek into Developed and Developing Economies
    • Increasing Market Availability of Personalized Medicines
    • Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area
    • Constraints in Traditional Approach to Treatment Creates Need and Demand for Personalized Medicine
    • Economics of Personalized Medicine
    • Is Emergence of Personalized Medicine Signaling the End of Blockbusters?
    • Personalized Medicines - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Molecular, Inc. (USA)
    • Beckman Coulter Genomics (USA)
    • bioMerieux SA (France)
    • Bristol-Myers Squibb Company (USA)
    • Dako Denmark A/S (Denmark)
    • F. Hoffmann-La Roche Ltd. (Switzerland)
    • GlaxoSmithKline plc. (UK)
    • Hologic, Inc. (USA)
    • Lab 21 Limited (UK)
    • Macrogen, Inc. (Korea)
    • NeoGenomics Laboratories, Inc. (USA)
    • Novartis AG (Switzerland)
    • QIAGEN NV (The Netherlands)
    • Rosetta Genomics Ltd (Israel)
    • Thermo Fisher Scientific Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Growth Drivers in a Gist
    • Key Market Restraints
    • Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
    • Oncology - A Major Application Market
    • Diagnosed Cases of Cancer on the Rise
    • World Cancer Statistics: Incidence and Mortality Data
    • Growing Cancer Cases in Developing Countries Bodes Well for the Personalized Medicine Market
    • Growing Importance of Personalized Drugs for Cancer Treatment
    • Ballooning Global Population Offers Significant Growth Opportunities
    • Aging Global Population Drives Personalized Medicines
    • Increasing Healthcare Spending in Emerging Markets
    • Changing Patients' Trends Drive Personalized Medicine
    • Technological Advancements and Consumer Push to Drive Personalized Medicine
    • Minimizing Adverse Events - A Major Benefit of Personalized Medicines
    • Personalized Medicines Brings Disease Prevention Closer to Reality
    • Ability to Manage Healthcare Costs Piques Industry and Government Alike
    • Potential to Uncover Additional Prospective Targets - A Major Benefit in Pursuit
    • Elimination of Invasive Tests Attracts Patients and Doctors towards Molecular Test-based Personalized Medicines
    • Genomics to Dictate Advancement of Personalized Medicines
    • Companion Diagnostics Drive Personalized Medicine
    • Biomarkers as Companion Diagnostics
    • Personalized Medicines Help Reducing R&D Costs
    • Personalized Medicine - A Corporate Growth Strategy
    • Development Pipeline Reveals Promising Picture for Personalized Medicine
    • Advancements in Biomedical Imaging to Enhance Personalized Medicines
    • Increasing Use of Personalized Medicines Drives Genetic Testing
    • Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market
    • Next-Generation Sequencing - A Giant Leap in Genome Sequencing
    • Single Nucleotide Polymorphism (SNP) - Making Advancements in Personalized Medicine
    • Personalized Medicine Goes Beyond DNA Analysis
    • Combination Approaches May Mark Future Endeavors
    • Need for New Designs in Clinical Trials Emerges in Therapies for Rare Cancers
    • Immunotherapy for Cancers - A Potential Breakthrough in the Sector
    • Personalized Medicine Industry - Inundated with Data
    • Advanced Computing Technologies - The Need of The Hour to Analyze Large Data
    • Artificial Intelligence Revolutionizing Personalized Medicine
    • Challenges Aplenty for Precision Medicine
    • Lack of Clinically Useful Diagnostic Tests - Growth Dampener
    • Pricing and Value Dilemma Haunts Personalized Medicines
    • Bedside Biopharmaceutical Production to Dramatically Reduce Cost of Personalized Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Personalized Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Personalized Nutrition & Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Personalized Nutrition & Wellness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Personalized Medical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Personalized Medical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Personalized Medicine Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Personalized Medicine Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Personalized Medicine Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Personalized Medicine Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Personalized Medicines Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 19: USA 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 22: Canada 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • JAPAN
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 25: Japan 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • CHINA
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: China 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • EUROPE
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Personalized Medicines by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: Europe 18-Year Perspective for Personalized Medicines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Europe 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • FRANCE
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: France 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • GERMANY
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: Germany 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Italy 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: UK 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: Rest of Europe 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Personalized Medicines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Asia-Pacific 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Personalized Medicines by Product - Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Rest of World 18-Year Perspective for Personalized Medicines by Product - Percentage Breakdown of Value Sales for Personalized Nutrition & Wellness, Personalized Medical Care, Personalized Medicine Diagnostics and Personalized Medicine Therapeutics for the Years 2012, 2023 & 2030

IV. COMPETITION